Basic information
Biomarker: sIL-2R
Histology type: endometrial carcinoma
Cohort characteristics
Country: Italy
Region: Università di Pisa
Followed up time :
Subgroup 1 name : elevated serum levels
Subgroup 1 number: 18
Subgroup 2 name: none elevated serum levels
Subgroup 2 number: 17
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
183 | EC | 35 | benign uterine diseases | 102 | cervical cancer | 46 |
Sample information
Conclusion: On the other hand, we observed that sIL-2R was the most sensitive antigen for endometrial cancer; therefore it could represent a new tumor marker for the management of patients with this malignancy.
Sample type : serum
Expression pattern : raised serum concentrations (> or = 50 U/mL)
Disease information
Related information
Funtion Uniprot: Receptor for interleukin-2. The receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells.
UniProt ID: P01589
UniProt Link: https://www.uniprot.org/uniprotkb/P01589/entry
Biological function from UniProt: #Immunity
Molecular function from UniProt:
Subcellular UniProt: #Membrane
Alternative name from UniProt:
Recommended name: Interleukin-2 receptor subunit alpha
Gene name from HGNC: IL2RA (CD25, IDDM10, IL2R)
CD antigen name: CD25
HPA class: Cancer-related genes CD markers Disease related genes FDA approved drug targets Human disease related genes Plasma proteins
AlphaFold DB: P01589
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P01589
HPA link: https://www.proteinatlas.org/ENSG00000134460-IL2RA
Tissue specificity RNA from HPA: Tissue enhanced (adipose tissue, lymphoid tissue, urinary bladder)
Tissue expression from HPA: Cytoplasmic expression in a subset of immune cells in several tissues, including lymphoid organs and gastrointestinal tract.
Single cell type specificity Group enriched (monocytes, granulocytes)
Immune cell specificity: Group enriched (T-reg, basophil)
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000134460-IL2RA/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000134460-IL2RA/pathology/endometrial+cancer
Phenotype ID: 601942
Disease: Diabetes mellitus, insulin-dependent, 10 (IDDM10);Immunodeficiency 41 with lymphoproliferation and autoimmunity (IMD41);
Note1: Disease susceptibility is associated with variants affecting the gene represented in this entry;The disease is caused by variants affecting the gene represented in this entry;
OMIM: 147730
OMIM link1: https://www.omim.org/entry/601942;https://www.omim.org/entry/606367;
OMIM link2: https://www.omim.org/entry/147730
HGNC ID: HGNC:6008
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6008